Oncolytics Biotech(R) announces closing of public offering of common shares and warrants
Oncolytics Biotech® announced closing of its previously announced underwritten public offering. Oncolytics sold 4,619,773 common shares and warrants to purchase up to 4,619,773 common shares, at a purchase price of USD $0.81 per share and warrant, for gross proceeds of $3.7 million. August 16, 2019